Catestatin is a multifunctional peptide that is involved in the regulation of the cardiovascular
and immune systems as well as metabolic homeostatis. It mitigates detrimental, excessive …

Chromogranin A (CgA), B (CgB), and C (CgC), the family members of the granin
glycoproteins, are associated with diabetes. These proteins are abundantly expressed in …

Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular
activities. Conflicting results have been recently reported by increased or decreased plasma …

Background: Cardiovascular disease (CVD), the most common cause of death globally,
accounts for~ 30% of all deaths worldwide. Hypertension is a common contributor to …

Obesity, lipodystrophy, diabetes, and hypertension collectively constitute the main features
of Metabolic Syndrome (MetS), together with insulin resistance (IR), which is considered as …

Catestatin (CST) is an important peptide in the pathophysiology of chronic inflammatory
disorders. However, clinical studies on inflammatory bowel disease (IBD) patients are …

Atherosclerotic cardiovascular disease (ASCVD) stands as the leading global cause of
mortality. Addressing this vital and pervasive condition requires a multifaceted approach, in …

Chromogranin A (CgA), a secretory protein released in the blood by neuroendocrine cells
and neurons, is the precursor of various bioactive fragments involved in the regulation of the …

Catestatin can inhibit catecholamine release from chromaffin cells and adrenergic neurons.
Catestatin can also have a strong vasodilator effect. This may be useful in understanding the …

The rapid increase in drug-resistant and multidrug-resistant infections poses a serious
challenge to antimicrobial therapies, and has created a global health crisis. Since …